Failed NewLink goes dark in a reverse merger, as Lumos jumps on board for a ride to Wall Street
Three years ago shares of NewLink Genetics traveled at a lofty altitude above $50 a share, with some high hopes riding on IDO. Now those …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
